Most Triple-Negative Breast Cancers Express Muc-1 Target, Ireland Cancer Center Researcher Discovers

Research out of the Ireland Cancer Center of University Hospitals Case Medical Center has found that the vast majority of triple negative breast cancers express the MUC-1 target. This first-of-its-kind finding, presented at the San Antonio Breast Cancer Symposium, has paved the way for an upcoming vaccine trial for patients with early stage triple negative breast cancer that could potentially prevent recurrence of this aggressive type of breast cancer.

More: continued here

Filed under: Immune System / Vaccines on December 19th, 2008